Background: Though adiponectin has been associated with insulin resistance and cardiovascular risk factors, the relationship between adiponectin and polycystic ovary syndrome (PCOS) remains controversial. The aim of this study was to compare adiponectin level in women with PCOS and without PCOS, and to investigate the relationship between adiponectin level and metabolic variables including insulin resistance.
INTRODUCTION
Polycystic ovary syndrome (PCOS) is a common endocrine disorder 1) among women of child-bearing age. It is characterized by chronic anovulation (oligomenorrhea or amenorrhea)
hyperandrogenemia, hirsutism and acne. Recently, many studies have focused on the metabolic disorders in PCOS 2, 3) that lead to cardiovascular events, dyslipidemia, insulin resistance, 4, 5) and metabolic dysfunction is widely regarded as the leading cause of the syndrome.
Adiponectin is a cytokine produced and secreted exclusively from adipose tissue. It is believed to serve an anti-in ammatory role, as well as have anti-atherogenic and cardioprotective pro- 
Statistical Analysis
We analyzed all of the data using the SAS 9. 6) and an insulin-sensitizing effect. 7, 8) In addition, adiponectin levels are known to have an inverse relationship with insulin resistance in obesity, type 2 diabetes, dyslipidemia, hypertension and cardiovascular disease. In PCOS, however, the association between adiponectin levels and PCOS remains controversial [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] and it is unclear so far whether adiponectin is a primary defect or occurred secondary to or in parallel with this insulin resistance. [11] [12] [13] [14] 17) The aim of this study was to compare adiponectin levels in women with PCOS to those of healthy women, and to investigate the independent relationship between plasma adiponectin concentrations and metabolic variables including insulin resistance.
METHODS

Subjects
We included 60 women patients with PCOS and a control group of 80 healthy women, matched for age and BMI. PCOS subjects were enrolled when they had satisfied two of the three following criteria: oligomenorrhea or amenorrhea, clinical or biochemical hyperandrogenism, and ultrasonographic polycystic ovarian morphology. 19) We excluded the subjects who had weight- 
Methods
Anthropometric measurements were performed with sub- Table 3 .
DISCUSSION
PCOS is a complex hormonal and metabolic syndrome, com prising hyperandrogenemia, reproductive abnormalities, glucose intolerance, atherogenic lipid pro le, obesity and insulin RESULTS e characteristics of the PCOS and the control groups are summarized in Table 1 . Diastolic blood pressure, fasting glucose, TG, fasting insulin and CRP levels were all significantly higher in the PCOS group, while QUICKI, E2 and SHBG levels were significantly lower in the PCOS group. After adjustment for age, BMI, mean blood pressure, fasting glucose, fasting insulin, resistance. [22] [23] [24] e pathogenesis is not clear, but it is conceivably due to immature ovarian cysts and dysregulation of insulin signaling in theca cells resulting from genetic defects, extrinsic exposures, or both. 25) Adiponectin, a 247 amino acid polypeptide, secreted predominantly from adipose tissues, is inversely related with obesity, metabolic syndrome and insulin resistance. 7, 8, 20, 26, 27) e metabolic mechanism of adiponectin is not fully understood, but regulation of glucose and lipid metabolism via stimulation of fatty acid oxidation, suppression of hepatic glucose output and increased insulin sensitivity in liver and skeletal muscles are known to be key roles of adiponectin. 28, 29) In previous studies addressing the topic, the relationship between adiponectin and PCOS has been controversial, though a large proportion of such studies [9] [10] [11] [12] [13] have shown that low adiponectin levels were found in the PCOS group when compared to the control group. And it is unclear so far whether adipo nectin is a primary defect or occurred secondary to or in parallel with this insulin resistance. [11] [12] [13] [14] 17) In our study, the PCOS group had significantly lower adiponectin when compared to the non-PCOS group independently of insulin resistance or other metabolic factors. In addition, we found adiponectin correlated with insulin levels and QUICKI in both PCOS patients and control subjects, therefore, the association between adiponectin and insulin resistance indices does not represent a typical nding of PCOS status. Besides, our multivariate model shows that independent association between adiponectin and QUICKI was found only in the control group not in the PCOS group. is implies an alternative explanation other than insulin resistance should be needed with respect to those relationship.
An additional intriguing finding from our study is the fact that serum lipid profiles and BMI were independently correlated with adiponectin level in the PCOS group. Because regulation of fatty acid metabolism and obesity is closely associated with insulin resistance, 30) adiponectin might affect insulin resistance and metabolic abnormalities in PCOS through dysregulated lipid metabolism and obesity, although the exact pathway is unclear.
The salient limitation of our study was that we did not 
